Skip to main content
Log in

Takayasu’s arteritis associated with Crohn’s disease treated with infliximab

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

A 23-year-old woman presented with fever, diarrhea, bloody stools, and arthralgia that did not improve despite previous treatments and was diagnosed with Crohn’s disease. Remission was achieved after the introduction of infliximab, nutritional therapy, and 5-aminosalicylic acid treatment. However, the patient’s blood sedimentation rate remained elevated without symptom recurrence, except for abdominal pain in the following year. Aortic wall thickening in the thoracic descending aorta was also observed on computed tomography. Accumulation in the thoracic descending aorta and abdominal aorta was confirmed using positron emission tomography–computed tomography. The patient was diagnosed with Takayasu’s arteritis. The patient’s abdominal symptoms resolved, and her blood sedimentation rate normalized after steroid administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380:1590–605.

    Article  PubMed  Google Scholar 

  2. Hata A, Noda M, Moriwaki R, et al. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54(Suppl):S155–63.

    Article  PubMed  Google Scholar 

  3. de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.

    Article  PubMed  Google Scholar 

  4. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55:481–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Yassinger S, Adelman R, Cantor D, et al. Association of inflammatory bowel disease and large vascular lesions. Gastroenterology. 1976;71:844–6.

    Article  CAS  PubMed  Google Scholar 

  6. Reny JL, Paul JF, Lefèbvre C, et al. Association of Takayasu’s arteritis and Crohn’s disease. Results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne (Paris). 2003;154:85–90.

    PubMed  Google Scholar 

  7. Farrant M, Mason JC, Wong NA, et al. Takayasu’s arteritis following Crohn’s disease in a young woman: any evidence for a common pathogenesis? World J Gastroenterol. 2008;14:4087–90.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kusunoki R, Ishihara S, Sato M, et al. rare case of Takayasu’s arteritis associated with Crohn’s disease. Intern Med. 2011;50:1581–5.

    Article  PubMed  Google Scholar 

  9. Yilmaz N, Can M, Alibaz-Oner F, et al. Clinically silent Crohn’s disease in a patient with Takayasu’s arteritis unresponsive to conventional therapies. Rheumatol Int. 2013;33:3091–3.

    Article  PubMed  Google Scholar 

  10. Pallone F, Monteleone G. Mechanisms of tissue damage in inflammatory bowel disease. Curr Opin Gastroenterol. 2001;17:307–12.

    Article  CAS  PubMed  Google Scholar 

  11. Terao C, Matsumura T, Yoshifuji H, et al. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol. 2015;67:2226–32.

    Article  PubMed  Google Scholar 

  12. Akiyama S, Fujii T, Matsuoka K, et al. Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis. J Gastroenterol Hepatol. 2017;32:1011–7.

    Article  CAS  PubMed  Google Scholar 

  13. Simon S, Schittko G, Bösenberg H, et al. Fulminant course of a Takayasu’s arteritis and rare mesenteric arterial maninfestion. Z Rheumatol. 2006;65:522–6.

    Google Scholar 

  14. Tripathy NK, Gupta PC, Nityanand S. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu’s arteritis. Clin Immunol. 2006;118:154–8.

    Article  CAS  PubMed  Google Scholar 

  15. Seko Y. Giant cell and Takayasu arteritis. Curr Opin Rheumatol. 2007;19:39–43.

    Article  PubMed  Google Scholar 

  16. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn’s disease activity index National cooperative Crohn’s disease study. Gastroenterology. 1976;70:439–44.

    Article  CAS  PubMed  Google Scholar 

  17. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Sy A, Khalidi N, Dehghan N, et al. Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature. Semin Arthritis Rheum. 2016;45:475–82.

    Article  PubMed  Google Scholar 

  19. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hall S, Barr W, Lie JT, et al. Takayasu’s arteritis. A study of 32 North American patients. Medicine. 1985;64:88–99.

    Article  Google Scholar 

  21. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919–29.

    Article  CAS  PubMed  Google Scholar 

  22. Nakaoka Y, Isobe M, Tanaka Y, et al. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. Rheumatology (Oxford). 2020;59:2427–34.

    Article  CAS  PubMed  Google Scholar 

  23. Domènech E, Garcia-Planella E, Olazábal A, et al. Abdominal aortitis associated with Crohn’s disease. Dig Dis Sci. 2005;50:1122–3.

    Article  PubMed  Google Scholar 

  24. Kellermayer R, Jain AK, Ferry G, et al. Clinical challenges and images in GI. Aortitis as a rare complication of Crohn’s disease. Gastroenterology. 2008;134:668–9.

    Article  PubMed  Google Scholar 

  25. El-Matary W, Persad R. Takayasu’s aortitis and infliximab. J Pediatr. 2009;155:151.

    Article  PubMed  Google Scholar 

  26. Katoh N, Kubota M, Shimojima Y, et al. Takayasu’s arteritis in a patient with Crohn’s disease: an unexpected association during infliximab therapy. Intern Med. 2010;49:179–82.

    Article  PubMed  Google Scholar 

  27. Ratuapli S, Mazlumzadeh M, Gurudu S, et al. Coexisting Crohn’s disease and Takayasu’s arteritis in two patients treated with Anti-TNF-α therapies. Case Rep Gastroenterol. 2010;4:35–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Osman M, Aaron S, Noga M, et al. Takayasu’s arteritis progression on anti-TNF biologics: a case series. Clin Rheumatol. 2011;30:703–6.

    Article  PubMed  Google Scholar 

  29. Miyakawa M, Tanaka H, Yamashita M, et al. A case of Takayasu’s arteritis detected in a patient with Crohn’s disease following infliximab treatment. Nihon Shokakibyo Gakkai Zasshi. 2016;113:1761–8.

    PubMed  Google Scholar 

  30. Talathi S, Mannion M, Colvin E, et al. Aortitis with an Aneurysm at initial presentation of Crohn disease. J Pediatr Gastroenterol Nutr. 2018;67:e12–3.

    Article  PubMed  Google Scholar 

  31. Takeuchi I, Kawai T, Nambu M, et al. X-linked inhibitor of apoptosis protein deficiency complicated with Crohn’s disease-like enterocolitis and Takayasu arteritis: a case report. Clin Immunol. 2020;217: 108495.

    Article  CAS  PubMed  Google Scholar 

  32. Kollen L, Werner O, Gavotto A. Uncommon cause of chest pain in a 9-year-old boy with Crohn’s disease. Gastroenterology. 2020;158:2055–7.

    Article  CAS  PubMed  Google Scholar 

  33. Polyakova I, Iannucci G, George R, et al. Simultaneous presentation of Crohn’s disease and Takayasu arteritis in a teenage patient. J Investig Med High Impact Case Rep. 2020;8:2324709620977317.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the reviewers for comments on an earlier version of this paper.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by HA. The first draft of the manuscript was written by HA and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hiroyuki Ariga.

Ethics declarations

Conflict of interest

The author declares no conflict of interest.

Research involving human participants and/or animals

All the procedures performed in the study were in accordance with the ethical standards of the institutional reviews board/international ethics committee for each center and with the 1964 Helsinki Declaration and its later ammendments.

Informed consent

All participants provided informed consent prior to their participation.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ariga, H., Chino, Y., Ojima, T. et al. Takayasu’s arteritis associated with Crohn’s disease treated with infliximab. Clin J Gastroenterol 17, 281–285 (2024). https://doi.org/10.1007/s12328-023-01904-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-023-01904-9

Keywords

Navigation